文献速递认知障碍与痴呆脑血管病

中年全身炎症标志物与晚年脑体积的关联:ARIC研究

Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study.
PubMed 文献 · Neurology · 2017-11-01

该前瞻性队列研究纳入1633名中年参与者,检测5种炎症标志物并构建复合评分,24年后用3T MRI评估脑体积和情景记忆。结果显示中年炎症水平越高,晚年脑室越大、海马和阿尔茨海默病特征区体积越小,情景记忆越差,提示全身炎症可能早期参与神经退行和认知老化。

要点

  • 中年炎症复合评分每升高1个标准差,晚年海马体积小110 mm³(p=0.013)。
  • 3种及以上炎症标志物升高者,海马和AD特征区体积平均小5%。
  • 炎症与脑体积的关联受年龄和种族修饰,年轻和白人参与者更明显。

核心结论

  • 中年全身炎症水平较高与24年后脑体积减小和情景记忆下降相关,提示炎症可能是神经退行和认知老化的早期 contributory 因素。

研究设计与样本

  • 前瞻性队列研究,纳入ARIC研究中1633名基线参与者(平均年龄53[5]岁,60%女性,27%非裔美国人)。
  • 基线检测血浆纤维蛋白原、白蛋白、白细胞计数、von Willebrand因子和因子VIII,并构建炎症复合评分。
  • 24年后使用3T MRI评估区域脑体积和情景记忆。

主要发现

  • 中年炎症复合评分每升高1个标准差,晚年脑室体积大1788 mm³(p=0.013),海马体积小110 mm³(p=0.013)。
  • 炎症复合评分每升高1个标准差,枕叶体积小519 mm³(p=0.009),阿尔茨海默病特征区体积小532 mm³(p=0.008),情景记忆下降(p=0.046)。
  • 与无炎症标志物升高(第4四分位)者相比,3种及以上标志物升高者海马和AD特征区体积平均小5%。
  • 中年炎症与晚年脑体积的关联受年龄和种族修饰,年轻参与者和白人参与者中关联更明显。

临床怎么用

  • 中年全身炎症标志物水平可能有助于识别晚年脑萎缩和认知下降的高风险个体。
  • 针对中年炎症的干预策略或可延缓神经退行和认知老化,需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To clarify the temporal relationship between systemic inflammation and neurodegeneration, we examined whether a higher level of circulating inflammatory markers during midlife was associated with smaller brain volumes in late life using a large biracial prospective cohort study. METHODS: Plasma levels of systemic inflammatory markers (fibrinogen, albumin, white blood cell count, von Willebrand factor, and Factor VIII) were assessed at baseline in 1,633 participants (mean age 53 [5] years, 60% female, 27% African American) enrolled in the Atherosclerosis Risk in Communities Study. Using all 5 inflammatory markers, an inflammation composite score was created for each participant. We assessed episodic memory and regional brain volumes, using 3T MRI, 24 years later. RESULTS: Each SD increase in midlife inflammation composite score was associated with 1,788 mm3 greater ventricular (p = 0.013), 110 mm3 smaller hippocampal (p = 0.013), 519 mm3 smaller occipital (p = 0.009), and 532 mm3 smaller Alzheimer disease signature region (p = 0.008) volumes, and reduced episodic memory (p = 0.046) 24 years later. Compared to participants with no elevated (4th quartile) midlife inflammatory markers, participants with elevations in 3 or more markers had, on average, 5% smaller hippocampal and Alzheimer disease signature region volumes. The association between midlife inflammation and late-life brain volume was modified by age and race, whereby younger participants and white participants with higher levels of systemic inflammation during midlife were more likely to show reduced brain volumes subsequently. CONCLUSIONS: Our prospective findings provide evidence for what may be an early contributory role of systemic inflammation in neurodegeneration and cognitive aging.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Walker KA, Hoogeveen RC, Folsom AR, et al. Midlife systemic inflammatory markers are associated with late-life brain volume: The ARIC study. Neurology. 2017. PMID: 29093073. doi:10.1212/WNL.0000000000004688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。